Product OverviewProduct Handling Videos
  1. Home / 
  2. Heraeus Medical at a Glance / 
  3. Press & News / 
  4. Heraeus Medical receives MDR approval for PALACOS® bone cements without gentamicin
Press release
07/03/2025

Heraeus Medical Receives MDR Approval for PALACOS® Bone Cements without Gentamicin

Corporate
Products

The certificate confirms the quality and safety of the products as well as the high production standards.

Heraeus Medical has received MDR approval for another product family, PALACOS® bone cements without gentamicin. These include PALACOS® R, PALACOS® MV, and PALACOS® LV. 

We are delighted and proud that our broad portfolio of bone cements with and without antibiotics is now fully certified in accordance with the strict requirements of MDR. This enables us to continue supplying our customers with high-quality, proven products, thereby ensuring the best possible care for patients.

Arthur Charlet

Co-President

Heraeus Medical

PALACOS® is a bone cement without gentamicin for the stable anchoring of total or partial joint endoprostheses in bone. It is also used to fill and stabilize bone defects within the scope of internal fixation treatment or for endoprosthetic revision surgery.

PALACOS® R was introduced in Germany in 1959 as the first bone cement. This marked the beginning of the success story of PALACOS® bone cements, which have been used in over 40 million procedures worldwide to date1 and are the most thoroughly investigated.2

1 Data on file at Heraeus Medical (in vitro).
2 Pilz V, Hanstein T. A Literature Review of the Clinical Evidence Situation of Bone Cements. Research & Reviews: Journal of Medical and Health Sciences 2018; 7(1): 31–36 (in vitro).

Andrea Pansegrau
Press Contact
Send Mail
+49 6181 35-2504

Heraeus Medical GmbHPhilipp-Reis-Str. 8-1361273 WehrheimGermany

Andrea Pansegrau